[HTML][HTML] A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel …
DM Patel, R Mateen, N Qaddour, A Carrillo… - Cancers, 2024 - mdpi.com
Simple Summary Metastatic urothelial carcinoma is sensitive to immunomodulation. Immune
checkpoint inhibitors (ICIs) have been FDA approved for use as single agents to treat locally …
checkpoint inhibitors (ICIs) have been FDA approved for use as single agents to treat locally …